GF Securities logo

GF Securities

Asia, Guangdong, China, Guangzhou

Description

GF Securities provides industry equity market services.

Investor Profile

GF Securities has backed more than 14 startups, with 4 new investments in the last 12 months alone. The firm has led 3 rounds, about 21% of its total and boasts 21 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Seed, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Biotechnology, Medical, Pharmaceutical.
  • Led 2 rounds in the past year.

Stage Focus

  • Series B (29%)
  • Seed (21%)
  • Post Ipo Equity (21%)
  • Series A (14%)
  • Private Equity (7%)
  • Series C (7%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
  • Health Care
  • Manufacturing
  • Clinical Trials
  • Financial Services
  • Therapeutics
  • Life Science
  • Asset Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GF Securities frequently co-invest with?

GH
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
Yonghua Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Droia Ventures
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Mass General Brigham
North America, Massachusetts, United States, Somerville
Co-Investments: 2
Quark Venture
North America, British Columbia, Canada, Vancouver
Co-Investments: 6
SE
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
NA
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
HC
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2

Which angels does GF Securities often collaborate with?

PF
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by GF Securities?

Hurrichip

Changping, Beijing, China

Hurrichip manufactures gallium nitride semiconductor lasers that is used during semiconductor testing.

Industrial ManufacturingManufacturingSemiconductor
Series BJul 1, 2025
Amount Raised: $41,884,817
Sanyou Medical

Shanghai, Shanghai, China

Sanyou Medical is a corporation that is therapy innovation oriented and devotes to the R&D.

Innovation ManagementMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 13, 2025
Amount Raised: $29,566,791
Xunchi Xunjie

Chongqing, Heilongjiang, China

Xunchi Xunjie is a new energy vehicle charging pile R&D and operation operator.

AutomotiveElectric Vehicle
Series AJan 9, 2025
Amount Raised: $21,824,828
Benlizu

Guangdong, Jilin, China

Benlizu is a one-stop provider of office smart equipment leasing services.

LeasingOffice SuppliesService Industry
SeedDec 19, 2024
Noematrix

Shanghai, Shanghai, China

Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.

Intelligent SystemsManufacturingRobotics
SeedSep 6, 2024
DFD

Jiaozuo, Henan, China

DFD is a high-tech enterprise engaged in the research, development, production and sales of high-performance inorganic fluorides.

EnterpriseManufacturing
Post Ipo EquityAug 17, 2023
Amount Raised: $274,672,453
Wensheng AMC

Shanghai, Shanghai, China

Wensheng AMC provides special opportunity investment and management services.

Asset ManagementBusiness DevelopmentFinanceFinancial Services
Private EquityJun 29, 2022
Volastra Therapeutics

New York, New York, United States

Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.

BiotechnologyLife ScienceMedical
SeedFeb 11, 2020
Amount Raised: $12,000,000
Lyndra Therapeutics

Watertown, Massachusetts, United States

Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.

BiotechnologyClinical TrialsHealth CarePharmaceutical
Series BFeb 11, 2019
Amount Raised: $60,900,000
Bioarray Therapeutics

Boston, Massachusetts, United States

Bioarray Therapeutics is a biotech company that is committed to transforming cancer treatment decisions and outcomes using gene profiling.

BiopharmaBiotechnologyMedicalOncology
Series BOct 5, 2017
Amount Raised: $4,000,000